The state announced Saturday it will resume administering the Johnson & Johnson COVID-19 vaccine shots. The news comes a day after the CDC lifted the pause after a rare blood clotting issue was discovered. Experts concluded the Johnson & Johnson COVID-19 vaccine is safe and effective. A review group said, “The benefits of these vaccines far outweighed the risks.”
As far as the risk of blood clots from the Johnson & Johnson vaccine, Stanford Dr. Jorge Caballero said “Our chance of getting struck by lightning is one in 500,000. So, this is half as rare as getting struck by lightning on any given year,” he said.
Still, there is some risk and during the 12-day pause, experts figured out some ways to manage those risks. The CDC and the review group came up with an effective treatment doctors can exercise if a patient does have a clotting reaction to the Johnson & Johnson shot.
